Medical Decision Making : A Health Economic Primer
by Stefan Felder, Thomas Mayrhofer
| Year of publication: |
2011
|
|---|---|
| Authors: | Felder, Stefan |
| Other Persons: | Mayrhofer, Thomas (contributor) |
| Publisher: |
Berlin, Heidelberg : Springer-Verlag Berlin Heidelberg |
| Subject: | Entscheidung unter Unsicherheit | Decision under uncertainty | Medizin | Medical sciences | Gesundheitsökonomik | Health economics | Theorie | Theory | Entscheidungsfindung | Ärztliche Behandlung | Entscheidung bei Unsicherheit | Gesundheitsökonomie |
| Description of contents: | Table of Contents [external.dandelon.com] |
| Extent: | Online-Ressource (XVII, 200p. 55 illus, digital) |
|---|---|
| Series: | |
| Type of publication: | Book / Working Paper |
| Language: | English |
| Notes: | Includes bibliographical references and index ""Medical Decision Making""; ""Preface""; ""Overview""; ""Contents""; ""List of Figures""; ""List of Tables""; ""List of Boxes""; ""Chapter 1: Introduction""; ""1.1 Outline""; ""1.2 Notes""; ""1.3 References""; ""Chapter 2: Basic Tools in Medical Decision Making""; ""2.1 Prevalence, Incidence and Risk""; ""2.2 Discriminatory Power and Prediction Values""; ""2.3 Probability, Odds and Likelihood Ratio""; ""2.4 Continuous Test Outcomes and Cutoff Points""; ""2.5 Notes""; ""2.6 Exercises""; ""2.7 References""; ""Chapter 3: Expected Utility, Risk Aversion and Prudence"" ""3.1 Menu of Actions, States of Nature and Consequences""""3.2 The Elementary Utility Function and the Expected Utility Rule""; ""3.3 The Axiom of Independence and the Expected Utility Rule""; ""3.4 The QALY Concept""; ""3.5 Risk Aversion""; ""3.6 Prudence""; ""3.7 Notes""; ""3.8 Exercises""; ""3.9 References""; ""Chapter 4: Treatment Decisions Without Diagnostic Tests""; ""4.1 The Treatment Decision Under Diagnostic Risk""; ""4.1.1 The Critical Prevalence Rate""; ""4.1.2 Risk Attitudes and the Treatment Decision""; ""4.1.3 Diagnostic Risk, Risk Aversion and the Severity of Illness"" ""4.2 The Treatment Decision Under Therapeutic Risk""""4.2.1 The Critical Success Probability""; ""4.2.2 The Role of Risk Attitude""; ""4.3 Notes""; ""4.4 Exercises""; ""4.5 References""; ""Chapter 5: Treatment Decisions with Diagnostic Tests""; ""5.1 The Value of Information of a Diagnostic Test""; ""5.1.1 The Perfect Test""; ""5.1.2 The Imperfect Test""; ""5.2 Risk Attitude and the Test and Treatment Thresholds""; ""5.2.1 The Perfect Test""; ""5.2.2 The Imperfect Test""; ""5.3 Potential Harm from a Test""; ""5.4 Notes""; ""5.5 Exercises""; ""5.6 References"" ""Chapter 6: Treatment Decisions Under Comorbidity Risk""""6.1 Prudence and the Critical Prevalence Rate""; ""6.2 Prudence and the Test and Treatment Decisions""; ""6.2.1 The Perfect Test""; ""6.2.2 The Imperfect Test""; ""6.3 Notes""; ""6.4 Exercises""; ""6.5 References""; ""Chapter 7: Optimal Strategy for Multiple Diagnostic Tests""; ""7.1 Choosing Among Two Tests""; ""7.2 Combining Two Tests""; ""7.3 Test and Treatment Thresholds for Composite Tests""; ""7.4 The Optimal Sequence of and Potential Harm from Testing""; ""7.5 Parallel or Sequential Testing?"" ""7.6 Cost-Benefit Analysis for Individual and Sequential Tests""""7.7 Notes""; ""7.8 Exercises""; ""7.9 References""; ""Chapter 8: The Optimal Cutoff Point of a Diagnostic Test""; ""8.1 Endogenous Test Characteristics""; ""8.2 The Optimal Cutoff Point""; ""8.3 Test and Treatment Thresholds and the Optimal Cutoff Point""; ""8.4 Multiple Tests with Endogenous Sensitivity and Specificity: Triple-Test and Amniocentesis""; ""8.4.1 The ROC Curve of the Triple Test""; ""8.4.2 The Value of Information and Optimal Use of the Triple Test with Amniocentesis""; ""8.4.3 Deciding on the Test Outcome"" ""8.5 Notes"" |
| ISBN: | 978-3-642-18330-0 ; 978-3-642-18329-4 |
| Other identifiers: | 10.1007/978-3-642-18330-0 [DOI] |
| Classification: | Gesundheitsökonomie |
| Source: | ECONIS - Online Catalogue of the ZBW |
Persistent link: https://www.econbiz.de/10014015394